A. N. Vorobyev

A. N. Vorobyev

Auto-generated profile, based on publicly available information

A. N. Vorobyev

Ryazan State Medical University named after academician I.P. Pavlov

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2019 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
MLM. M. Loukianov
M. M. Loukianov
SMS. Yu. Martsevich
S. Yu. Martsevich
ODO. M. Drapkina
O. M. Drapkina
SYSergey S. Yakushin
Sergey S. Yakushin
AVA. N. Vorobyev
A. N. Vorobyev
SBS. A. Boytsov
S. A. Boytsov
Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled in outpatient and hospital RECVASA registries.Material and methods. 3169 patients with AF were enrolled in outpatient registries RECVASA (Ryazan), RECVASA AF-Yaroslavl and hospital registries RECVASA AF (Moscow, Kursk, Tula), age 70.9±10.7 years, 43.1% men. The incidence of OAC administration was evaluated in hospital and outpatient settings, including longterm follow-up period (2-6 years).Results. OAC were administrated only in 42.2% of cases (1335 from 3169 patients; age 69.1±10.4 years, 43% men), including warfarin (817 patients; 26%) and non-vitamin K antagonist oral anticoagulants (NOAC) – 518 (16%). Patients with permanent and persistant types of AF had lower incidence of OAC administration (43% and 40%) than in cases of paroxysmal type (47.6%, p<0.05), despite of the higher СНА2DS2-VASc risk score (4.69±1.66 and 4.23±1.57 vs 3.81±1.69; р0.05) contrary to the pronounced difference of thromboembolic risk in these groups (6.14±1.34 and 3.77±1.39; р<0.001). The incidence of OAC administration in hospitals (54.1%) was 2.3 times higher than before hospitalization (23.8%) and was 4.1 times higher than in outpatient registries (13.5%). During follow-up period after hospital treatment (2.3±0.9 years) this parameter decreased from 54.1% to 41.2%, but was still 1.8 times higher than before admission to the hospital. After 4 years follow-up in RECVASA (Ryazan) registry we revealed 4.4 times higher incidence of OAC administration compared with enrollment data (4.2% and 18.3%, р<0.0001). This data was confirmed by the information from outpatient medical cards of accidentally generated group (75 from 297 patients survived during follow-up period): 5.3% at baseline and 22.7% six years later.Conclusions. RECVASA registries in 5 regions of Russia revealed low incidence of OAC administration. The risk of thromboembolic events was higher in patients with AF and no OAC administration compared with patients who received OAC. Patients with paroxysmal type of AF received OAC more often than those with permanent type. There were no significant differences of incidence of OAC therapy in patients with and without history of stroke. Both questioning of patients with AF and analysis of medical cards in outpatient clinics revealed higher incidence of OAC administration after 4-6 years of follow-up compared with the stage of enrollment in registries.

23 November 2015 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
SBSergey Boytsov
Sergey Boytsov
МLМ. М. Lukyanov
М. М. Lukyanov
SYSergey S. Yakushin
Sergey S. Yakushin
SMS. Yu. Martsevich
S. Yu. Martsevich
AVA. N. Vorobyev
A. N. Vorobyev
AКArray В. Кудряшов
Array В. Кудряшов
АМБУЛАТОРНО-ПОЛИКЛИНИЧЕСКИЙ РЕГИСТР РЕКВАЗА: ДАННЫЕ ПРОСПЕКТИВНОГО НАБЛЮДЕНИЯ, ОЦЕНКА РИСКА И ИСХОДЫ У БОЛЬНЫХ С КАРДИОВАСКУЛЯРНЫМИ ЗАБОЛЕВАНИЯМИ

1 January 2016 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
AZA. V. Zagrebelnyi
A. V. Zagrebelnyi
SMS. Yu. Martsevich
S. Yu. Martsevich
MLM. M. Lukyanov
M. M. Lukyanov
AVA. N. Vorobyev
A. N. Vorobyev
KMK. A. Moseichuk
K. A. Moseichuk
SBSergey Boytsov
Sergey Boytsov
Издательство Медиа Сфера - 25 медицинских журналов общим тиражом около 500 000 экземпляров в год, представлены в международных базах данных Scopus, Medline, и Google Scolar, включены в перечень изданий ВАК, представлены в РИНЦ

5 March 2018 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
MLM. M. Loukianov
M. M. Loukianov
SMS. Yu. Martsevich
S. Yu. Martsevich
SYSergey S. Yakushin
Sergey S. Yakushin
AVA. N. Vorobyev
A. N. Vorobyev
KPKristina Pereverzeva
Kristina Pereverzeva
SBSergey Boytsov
Sergey Boytsov
THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES

3 November 2021 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
MLM. M. Loukianov
M. M. Loukianov
SMS. Yu. Martsevich
S. Yu. Martsevich
EAE. Yu. Andrenko
E. Yu. Andrenko
SYSergey S. Yakushin
Sergey S. Yakushin
AVA. N. Vorobiev
A. N. Vorobiev
ODOxana M. Drapkina
Oxana M. Drapkina
Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials and methods. 3169 patients with AF were enrolled in outpatient RECVASA (Ryazan), RECVASA AF-Yaroslavl registries and hospital RECVASA AF (Moscow, Kursk, Tula). 2497 (78.8%) registries of patients with AF had CAD and 703 (28.2%) of them had a previous myocardial infarction (MI).Results. There were 2,497 patients with a combination of AF and CAD (age was 72.2±9.9 years; 43.1% of men; CHA2DS2-VASc – 4.57±1.61 points; HAS-BLED – 1.60±0,75 points), and the group with AF without CAD included 672 patients (age was 66.0±12.3 years; 43.2% of men; CHA2DS2-VASc – 3.26±1.67 points; HAS-BLED – 1,11±0.74 points). Patients with CAD were on average 6.2 years older and had a higher risk of thromboembolic and hemorrhagic complications (p<0.05). 703 patients with a combination of AF and CAD had the previous myocardial infarction (MI; age was 72.3±9.5 years; 55.2% of men; CHA2DS2-VASc – 4.57±1.61; HAS-BLED – 1.65±0.76), and 1794 patients didn't have previous MI (age was 72.2±10.0 years; 38.4% of men; CHA2DS2-VASc – 4.30±1.50; HAS-BLED – 1.58±0.78). The proportion of men was 1.4 times higher among those with the previous MI. Patients with a combination of AF and CAD significantly more often (p <0.0001) than in the absence of CAD received a diagnosis of hypertension (93.8% and 78.6%), chronic heart failure (90.1% and 51.2%), diabetes mellitus (21.4% and 13.8%), chronic kidney disease (24.8% and 17.7%), as well as anemia (7.0% and 3.0%; p=0.001). Patients with and without the previous MI had the only significant difference in the form of a diabetes mellitus higher incidence having the previous MI (27% versus 19.2%, p=0.0008). The frequency of proper cardiovascular pharmacotherapy was insufficient, mainly in the presence of CAD (67.8%) than in its absence (74.5%), especially the prescription of anticoagulants (39.1% and 66.2%; p <0.0001), as well as in the presence of the previous MI (63.3%) than in its absence (74.3%). The presence of CAD and, in particular, the previous MI, was significantly associated with a higher risk of death (risk ratio [RR]=1.58; 95% confidence interval [CI] was 1.33-1.88; p <0.001 and RR=1.59; 95% CI was 1.33-1.90; p <0.001), as well as with a higher risk of developing a combined cardiovascular endpoint (RR=1.88; 95% CI was 1.17-3 , 00; p <0.001 and RR=1.75; 95% CI was 1.44-2.12; p<0.001, respectively).Conclusion. 78.8% of patients from AF registries in 5 regions of Russia were diagnosed with CAD, of which 28.2% had previously suffered myocardial infarction. Patients with a combination of AF and CAD more often than in the absence of CAD had hypertension, chronic heart failure, diabetes, chronic kidney disease and anemia. Patients with the previous MI had higher incidence of diabetes than those without the previous MI. The frequency of proper cardiovascular pharmacotherapy was insufficient, and to a greater extent in the presence of CAD and the previous MI than in their absence. All-cause mortality was recorded in patients with a combination of AF and CAD more often than in the absence of CAD. All-cause mortality and the incidence of nonfatal myocardial infarction were higher in patients with AF and the previous MI than in those without the previous MI. The presence of CAD and, in particular, the previous MI, was significantly associated with a higher risk of death, as well as a higher risk of developing a combined cardiovascular endpoint.

8 July 2019 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
EFE. V. Filippov
E. V. Filippov
AVA. N. Vorobyev
A. N. Vorobyev
NDN. V. Dobrynina
N. V. Dobrynina
LZLiudmila Zotova
Liudmila Zotova
ELE. V. Lygina
E. V. Lygina
SYSergey S. Yakushin
Sergey S. Yakushin
Неблагоприятные сердечно-сосудистые исходы и их связь с факторами риска по данным проспективного исследования МЕРИДИАН-РО